• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二十一世纪疟疾消除面临的挑战:与行动相关的研究是关键。

The challenge of malaria eradication in the twenty-first century: research linked to operations is the key.

机构信息

Fogarty International Center, National Institutes of Health, 16 Center Drive, Bethesda, MD 20892, USA.

出版信息

Vaccine. 2011 Dec 30;29 Suppl 4:D97-103. doi: 10.1016/j.vaccine.2011.12.003. Epub 2012 Jan 26.

DOI:10.1016/j.vaccine.2011.12.003
PMID:22284402
Abstract

Interest and support for malaria control, eradication, and research has increased greatly over the past decade. This has resulted from appreciation of the huge medical, social, and economic burden that malaria exacts from endemic populations. Recent breakthroughs in drug development (artemisinin-based combination treatments), preventive interventions (long-lasting, insecticide-treated bed nets), improved diagnosis (rapid diagnostic tests), and community mobilization have resulted in deployment of new antimalarial tools. National programs supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, the U.S. President's Malaria Initiative, and other donors have resulted in substantial reductions in malaria morbidity and mortality. Bill and Melinda Gates have given great impetus to eradication with support for the development of key research strategies and direct funding of innovative research projects, including malaria vaccine and drug discovery, that could decrease disease and transmission. Linking research to field operations is a strategy that succeeded for smallpox eradication and will be required for the demise of malaria.

摘要

在过去的十年中,人们对疟疾控制、消除和研究的兴趣和支持大大增加。这是因为人们认识到疟疾给流行地区的人口带来了巨大的医疗、社会和经济负担。最近在药物开发(青蒿素为基础的联合疗法)、预防干预(长效、经杀虫剂处理的蚊帐)、改进诊断(快速诊断测试)和社区动员方面取得的突破,导致了新的抗疟工具的部署。在全球抗击艾滋病、结核病和疟疾基金、美国总统疟疾倡议以及其他捐助者的支持下,各国开展了国家规划,使得疟疾发病率和死亡率大幅下降。比尔和梅林达·盖茨大力推动消除疟疾,支持制定关键研究战略,并直接为创新研究项目提供资金,包括疟疾疫苗和药物发现,这将有助于减少疾病和传播。将研究与实地行动联系起来是一种成功的策略,天花的消除就是如此,疟疾的消除也需要这种策略。

相似文献

1
The challenge of malaria eradication in the twenty-first century: research linked to operations is the key.二十一世纪疟疾消除面临的挑战:与行动相关的研究是关键。
Vaccine. 2011 Dec 30;29 Suppl 4:D97-103. doi: 10.1016/j.vaccine.2011.12.003. Epub 2012 Jan 26.
2
Conquering the intolerable burden of malaria: what's new, what's needed: a summary.战胜疟疾的沉重负担:新进展与需求总结
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15.
3
From malaria control to eradication: The WHO perspective.从疟疾控制到消除:世界卫生组织的观点。
Trop Med Int Health. 2009 Jul;14(7):802-9. doi: 10.1111/j.1365-3156.2009.02287.x. Epub 2009 May 26.
4
Are multilateral malaria research and control programs the most successful? Lessons from the past 100 years in Africa.多边疟疾研究与控制项目是最成功的吗?非洲过去100年的经验教训。
Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):268-78.
5
[Malaria is still a leading cause of fever and death among children and pregnant women in Africa in 2015].2015年,疟疾仍是非洲儿童和孕妇发热及死亡的主要原因。
Bull Acad Natl Med. 2016 Mar;200(3):453-66.
6
[On the way to eradicating malaria].[在根除疟疾的道路上]
Ned Tijdschr Geneeskd. 2012;156(5):A4095.
7
Progress towards malaria elimination in Zimbabwe with special reference to the period 2003-2015.津巴布韦消除疟疾的进展,特别提到 2003-2015 年期间。
Malar J. 2017 Jul 24;16(1):295. doi: 10.1186/s12936-017-1939-0.
8
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!以青蒿素为基础的联合疗法(ACTs):疟疾治疗的最大希望,但贫困人群难以获得!
Acta Trop. 2005 Sep;95(3):305-15. doi: 10.1016/j.actatropica.2005.06.009.
9
Eradicating malaria.根除疟疾。
Sci Prog. 2009;92(Pt 1):1-38. doi: 10.3184/003685009X440290.
10
Can malaria be eliminated?疟疾能否被消除?
Trans R Soc Trop Med Hyg. 2009 Apr;103 Suppl 1:S2-5. doi: 10.1016/j.trstmh.2008.10.027. Epub 2008 Dec 4.

引用本文的文献

1
DDX17 is an RNA helicase crucial for parasite development.DDX17是一种对寄生虫发育至关重要的RNA解旋酶。
Biochem Biophys Rep. 2021 Apr 18;26:101000. doi: 10.1016/j.bbrep.2021.101000. eCollection 2021 Jul.
2
Species composition, blood meal hosts and Plasmodium infection rates of Anopheles mosquitoes in Ghibe River Basin, southwestern Ethiopia.埃塞俄比亚西南部吉贝河流域按蚊的种类组成、血食源和疟原虫感染率。
Parasit Vectors. 2019 May 23;12(1):257. doi: 10.1186/s13071-019-3499-3.
3
Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria.
青蒿素类复方疗法治疗无并发症恶性疟后配子体的感染性差异
Afr J Lab Med. 2018 Dec 6;7(2):784. doi: 10.4102/ajlm.v7i2.784. eCollection 2018.
4
Bone Marrow Is a Major Parasite Reservoir in Plasmodium vivax Infection.骨髓是间日疟原虫感染的主要寄生虫储存库。
mBio. 2018 May 8;9(3):e00625-18. doi: 10.1128/mBio.00625-18.
5
Malaria training for community health workers in the setting of elimination: a qualitative study from China.消除疟疾背景下的社区卫生工作者疟疾培训:来自中国的定性研究。
Malar J. 2018 Feb 23;17(1):95. doi: 10.1186/s12936-018-2229-1.
6
Use of different transmission metrics to describe malaria epidemiology in the highlands of western Kenya.使用不同传播指标描述肯尼亚西部高地的疟疾流行病学情况。
Malar J. 2015 Oct 26;14:418. doi: 10.1186/s12936-015-0944-4.
7
Determinants of low socio-economic status and risk of Plasmodium vivax malaria infection in Panama (2009-2012): a case-control study.巴拿马(2009 - 2012年)间社会经济地位低下与间日疟原虫疟疾感染风险的决定因素:一项病例对照研究
Malar J. 2015 Jan 21;14:14. doi: 10.1186/s12936-014-0529-7.
8
Malariometric indices from Iganga, Uganda: baseline characterization in preparation of GMZ2 vaccine trial.乌干达伊甘加的疟疾测量指标:GMZ2疫苗试验准备中的基线特征描述
BMC Res Notes. 2014 Nov 8;7:793. doi: 10.1186/1756-0500-7-793.
9
Ongoing surveillance for lymphatic filariasis in Togo: assessment of alternatives and nationwide reassessment of transmission status.多哥淋巴丝虫病的持续监测:替代方案评估和全国范围内传播状况重新评估。
Am J Trop Med Hyg. 2014 Jan;90(1):89-95. doi: 10.4269/ajtmh.13-0407. Epub 2013 Nov 4.
10
Research gaps for three main tropical diseases in the People's Republic of China.中国三种主要热带病的研究空白。
Infect Dis Poverty. 2013 Jul 29;2(1):15. doi: 10.1186/2049-9957-2-15.